Superficial vein thrombosis

Joseph A. Caprini*, Michael J. Verta

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


Superficial vein thrombosis (SVT), also known as superficial thrombophlebitis, is historically thought of as a benign condition that can always be treated symptomatically with nonsteroidal antiinflammatory drugs (NSAIDs) and elastic compression. However, many studies have reported an association of SVT with venous thromboembolism (VTE), with rates of concomitant deep vein thrombosis (DVT) as high as 53% and pulmonary embolism (PE) as high as 33% with lung scanning. In addition, SVT recurrence and extension is often reported. Although well-designed, randomized, controlled trials are few in this patient population, data suggest that anticoagulation in general and low-molecular-weight heparins specifically are the most effective treatment for SVT for resolving symptoms, preventing SVT recurrence or extension, and preventing VTE. When the significant morbidity and mortality associated with VTE is considered, it is reasonable that anticoagulation be used in all patients with SVT.

Original languageEnglish (US)
Title of host publicationPractical Approach to the Management and Treatment of Venous Disorders
PublisherSpringer-Verlag London Ltd
Number of pages13
ISBN (Electronic)9781447128915
ISBN (Print)1447128907, 9781447128908
StatePublished - Jul 1 2013

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Superficial vein thrombosis'. Together they form a unique fingerprint.

Cite this